Patents by Inventor Scott Wilbur

Scott Wilbur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230131121
    Abstract: Disclosed are general and “substantially pure” branched discrete polyethylene glycol constructs useful in attaching to a variety of biologically active groups, for example, preferential locators, as well as biologics like enzymes, for use in diagnostics, e.g. imaging, therapeutics, theranostics, and moieties specific for other applications. In its simplest intermediate state, a branched branched discrete polyethylene glycol construct is terminated at one end by a chemically reactive moiety, “A”, a group that is reactive with a biologic material that creates “A”, which is a biologically reactive group, connected through to a branched core (BC) which has attached at least two dPEG-containing chains, indicated by the solid line, , having terminal groups, which can be charged, non-reactive or reactable moieties and containing between about 2 and 64 dPEG residues.
    Type: Application
    Filed: May 27, 2022
    Publication date: April 27, 2023
    Inventors: Paul D. DAVIS, D. Scott WILBUR
  • Patent number: 11505525
    Abstract: Disclosed are general and “substantially pure” branched discrete polyethylene glycol constructs useful in attaching to a variety of biologically active groups, for example, preferential locators, as well as biologics like enzymes, for use in diagnostics, e.g. imaging, therapeutics, theranostics, and moieties specific for other applications. In its simplest intermediate state, a branched discrete polyethylene glycol construct is terminated at one end by a chemically reactive moiety, “A”, a group that is reactive with a biologic material that creates “A”, which is a biologically reactive group, connected through to a branched core (BC) which has attached at least two dPEG-containing chains, indicated by the solid line, , having terminal groups, which can be charged, non-reactive or reactable moieties and containing between about 2 and 64 dPEG residues.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: November 22, 2022
    Assignees: Quanta BioDesign, Ltd., University of Washington
    Inventors: Paul D. Davis, D. Scott Wilbur
  • Publication number: 20220354974
    Abstract: Reagents and methods for labeling biomolecules with astatine isotopes in higher oxidation states. The reagents and methods allow for efficient labeling of biomolecules, such as antibodies, without the formation of high molecular weight by products that arise due to 211At-promoted dimerization and higher aggregation of the conjugated biomolecules, and diminish cellular retention of astatine caused by cellular oxidization of the bonded astatine atom in vivo.
    Type: Application
    Filed: April 26, 2022
    Publication date: November 10, 2022
    Applicant: University of Washington
    Inventors: D. Scott Wilbur, Ming-Kuan Chyan, Donald K. Hamlin
  • Publication number: 20200317612
    Abstract: Disclosed are general and “substantially pure” branched discrete polyethylene glycol constructs useful in attaching to a variety of biologically active groups, for example, preferential locators, as well as biologics like enzymes, for use in diagnostics, e.g. imaging, therapeutics, theranostics, and moieties specific for other applications. In its simplest intermediate state, a branched branched discrete polyethylene glycol construct is terminated at one end by a chemically reactive moiety, “A”, a group that is reactive with a biologic material that creates “A”, which is a biologically reactive group, connected through to a branched core (BC) which has attached at least two dPEG-containing chains, indicated by the solid line, , having terminal groups, which can be charged, non-reactive or reactable moieties and containing between about 2 and 64 dPEG residues.
    Type: Application
    Filed: October 10, 2019
    Publication date: October 8, 2020
    Applicants: Quanta BioDesign, Ltd, University of Washington
    Inventors: Paul D. Davis, D. Scott Wilbur
  • Publication number: 20170313656
    Abstract: Disclosed are general and “substantially pure” branched discrete polyethylene glycol constructs useful in attaching to a variety of biologically active groups, for example, preferential locators, as well as biologics like enzymes, for use in diagnostics, e.g. imaging, therapeutics, theranostics, and moieties specific for other applications. In its simplest intermediate state, a branched discrete polyethylene glycol construct is terminated at one end by a chemically reactive moiety, “A”, a group that is reactive with a biologic material that creates “A”, which is a biologically reactive group, connected through to a branched core (BC) which has attached at least two dPEG-containing chains, indicated by the solid line, , having terminal groups, which can be charged, non-reactive or reactable moieties and containing between about 2 and 64 dPEG residues.
    Type: Application
    Filed: June 23, 2017
    Publication date: November 2, 2017
    Inventors: Paul D. Davis, D. Scott Wilbur
  • Publication number: 20160053345
    Abstract: This disclosure relates to methods for purifying and isolating astatine-211 from bismuth metal. Also disclosed are automated methods for purifying and isolating astatine-211 from bismuth metal.
    Type: Application
    Filed: August 21, 2015
    Publication date: February 25, 2016
    Inventors: D. Scott Wilbur, Ming-Kuan Chyan, Donald K. Hamlin, Katherine Gagnon, Shigeki Watanabe
  • Patent number: 8951499
    Abstract: A reagent for conjugation to a biomolecule, wherein the reagent is a single molecule with at least three functional parts and has schematic structure (I): a) wherein a trifunctional cross-linking moiety is coupled to b) an affinity ligand via a linker 1, said affinity ligand being capable of binding with another molecule having affinity for said ligand, to c) an effector agent, optionally via a linker 2, said effector agent exerting its effect on cells, tissues and/or humorous molecules in vivo or ex vivo, and to d) a biomolecule reactive moiety, optionally via a linker 3, said moiety being capable of forming a bond between the reagent and the biomolecule.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: February 10, 2015
    Assignees: University of Washington, Glycorex Transplantation AB
    Inventors: D. Scott Wilbur, Bengt E. B. Sandberg
  • Publication number: 20140179877
    Abstract: The invention relates to a macromolecule comprising a polymer central core having at least two atoms to which at least two monomers are attached forming a dendrimeric structure comprising at least three polymer bonds, at least two linear polymers (b) being bond to said polymer bonds, wherein said polymers (b) at least have terminal functional groups for cytotoxic agents and at least on extended polymer (a) having a size of at least 1 carbon atoms longer than said polymers (b) and at least a terminal functional group for a targeting agent. The invention also relates to a macromolecule conjugate as well as a macromolecule biotin conjugate comprising said macromolecule, methods to produce said macromolecules as well as kits or system comprising said macromolecules and method of treating a mammal by said macromolecules.
    Type: Application
    Filed: July 18, 2013
    Publication date: June 26, 2014
    Inventors: Rune NILSSON, Bengt SANDBERG, Scott WILBUR
  • Patent number: 8586177
    Abstract: Structural damage repair elements including inserts and a structural damage repair kit is provided. The structural damage repair elements typically include two or more layers of materials having an adhesive therebetween that are subsequently compressed together. The structural damage repair kit includes a chemical molding agent, an optional jig, one or more structural damage repair elements and a sealant. Both hollow and solid elongated objects, as well as relatively flat, curved objects may be repaired with the kit. The structural damage repair elements include rods, wafers, and/or adhesive saturated inserts.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: November 19, 2013
    Assignee: Scoda America, Inc.
    Inventors: Wesley Scott Wilbur, David Kip Wilbur
  • Patent number: 8480503
    Abstract: A bowling ball with an indicia is provided. A method for manufacturing such a bowling ball is also provided. The indicia may be preformed and attached to the core of the bowling ball before the outer layer of the bowling ball is created.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: July 9, 2013
    Assignee: Scoda America, Inc.
    Inventors: W. Scott Wilbur, David Wilbur, Harold Thommen, III, Kevin Keck
  • Publication number: 20130052130
    Abstract: Disclosed are general and “substantially pure” branched discrete polyethylene glycol constructs useful in attaching to a variety of biologically active groups, for example, preferential locators, as well as biologics like enzymes, for use in diagnostics, e.g. imaging, therapeutics, theranostics, and moieties specific for other applications. In its simplest intermediate state, a branched discrete polyethylene glycol construct is terminated at one end by a chemically reactive moiety, “A”, a group that is reactive with a biologic material that creates “A”, which is a biologically reactive group, connected through to a branched core (BC) which has attached at least two dPEG-containing chains, indicated by the solid line, , having terminal groups, which can be charged, non-reactive or reactable moieties and containing between about 2 and 64 dPEG residues.
    Type: Application
    Filed: August 30, 2012
    Publication date: February 28, 2013
    Applicants: UNIVERSITY OF WASHINGTON, QUANTA BIODESIGN, LTD.
    Inventors: Paul D. Davis, D. Scott Wilbur
  • Publication number: 20120252593
    Abstract: A bowling ball with an indicia is provided. A method for manufacturing such a bowling ball is also provided. The indicia may be preformed and attached to the core of the bowling ball before the outer layer of the bowling ball is created.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 4, 2012
    Inventors: W. Scott WILBUR, David Wilbur, Harold Thommen, III, Kevin Keck
  • Patent number: 8221252
    Abstract: A bowling ball with an indicia is provided. A method for manufacturing such a bowling ball is also provided. The indicia may be preformed and attached to the core of the bowling ball before the outer layer of the bowling ball is created.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: July 17, 2012
    Assignee: Scoda America, Inc.
    Inventors: W. Scott Wilbur, David Wilbur, Harold Thommen, III, Kevin Keck
  • Patent number: 8124364
    Abstract: A method for the conditioning of an extracorporeal device is described, as well as method for extracorporeal extraction of toxic material from mammalian body fluids in connection with diagnosis or treatment of a mammalian condition or disease, in which methods reagents having the ability to extract toxic material from mammalian body fluids are involved, and an extracorporeal device comprising said reagent.
    Type: Grant
    Filed: June 18, 2001
    Date of Patent: February 28, 2012
    Assignee: Glycorex Transplantation AB
    Inventors: Bengt Sandberg, Scott Wilbur, Rune Nilsson
  • Publication number: 20110014151
    Abstract: The invention relates to a macromolecule comprising a polymer central core having at least two atoms to which at least two monomers are attached forming a dendrimeric structure comprising at least three polymer bonds, at least two linear polymers (b) being bond to said polymer bonds, wherein said polymers (b) at least have terminal functional groups for cytotoxic agents and at least on extended polymer (a) having a size of at least 1 carbon atoms longer than said polymers (b) and at least a terminal functional group for a targeting agent. The invention also relates to a macromolecule conjugate as well as a macromolecule biotin conjugate comprising said macromolecule, methods to produce said macromolecules as well as kits or system comprising said macromolecules and method of treating a mammal by said macromolecules.
    Type: Application
    Filed: January 11, 2007
    Publication date: January 20, 2011
    Applicant: Biotech IgG AB
    Inventors: Rune Nilsson, Bengt Sandberg, Scott Wilbur
  • Publication number: 20100012257
    Abstract: Structural damage repair elements including inserts and a structural damage repair kit is provided. The structural damage repair elements typically include two or more layers of materials having an adhesive therebetween that are subsequently compressed together. The structural damage repair kit includes a chemical molding agent, an optional jig, one or more structural damage repair elements and a sealant. Both hollow and solid elongated objects, as well as relatively flat, curved objects may be repaired with the kit. The structural damage repair elements include rods, wafers, and/or adhesive saturated inserts.
    Type: Application
    Filed: September 24, 2009
    Publication date: January 21, 2010
    Inventors: Wesley Scott Wilbur, David Kip Wilbur
  • Publication number: 20090309255
    Abstract: A bowling ball with an indicia is provided. A method for manufacturing such a bowling ball is also provided. The indicia may be preformed and attached to the core of the bowling ball before the outer layer of the bowling ball is created.
    Type: Application
    Filed: March 12, 2009
    Publication date: December 17, 2009
    Inventors: W. Scott Wilbur, David Wilbur, Harold Thommen, III, Kevin Keck
  • Patent number: 7615129
    Abstract: Structural damage repair elements including inserts and a structural damage repair kit is provided. The structural damage repair elements typically include two or more layers of materials having an adhesive therebetween that are subsequently compressed together. The structural damage repair kit includes a chemical molding agent, an optional jig, one or more structural damage repair elements and a sealant. Both hollow and solid elongated objects, as well as relatively flat, curved objects may be repaired with the kit. The structural damage repair elements include rods, wafers, and/or adhesive saturated inserts.
    Type: Grant
    Filed: December 23, 2005
    Date of Patent: November 10, 2009
    Assignee: Scoda America, Inc.
    Inventors: Wesley Scott Wilbur, David Kip Wilbur
  • Patent number: 7141676
    Abstract: Water-soluble discrete multi-biotin-containing compounds with at least three (3) biotin moieties are disclosed. The water-soluble biotin-containing compounds may additionally comprise one or more moieties that confer resistance to cleavage by biotinidase or that is cleavable in vitro or in vivo. The discrete multi-biotin-containing compounds may include a reactive moiety that provides a site for reaction with yet another moiety, such as a targeting, diagnostic or therapeutic functional moiety. Biotinylation reagents comprising water-soluble linker moieties are also disclosed and may additionally comprise a biotinidase protective group. Methods for amplifying the number of sites for binding biotin-binding proteins at a selected target using multi-biotin compounds also are disclosed.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: November 28, 2006
    Assignee: University of Washington
    Inventors: D. Scott Wilbur, Pradip M. Pathare, Donald K. Hamlin, Feng Wan
  • Publication number: 20040052784
    Abstract: A method for the conditioning of an extracorporeal device is described, as well as method for extracorporeal extraction of toxic material from mammalian body fluids in connection with diagnosis or treatment of a mammalian condition or disease, in which methods reagents having the ability to extract toxic material from mammalian body fluids are involved, and an extracorporeal device comprising said reagent.
    Type: Application
    Filed: April 23, 2003
    Publication date: March 18, 2004
    Inventors: Bengt Sandberg, Scott Wilbur, Rune Nilsson